DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Kirchhof P, Radaideh G, Kim YH. , et al.
Safety analysis of rivaroxaban: a pooled analysis of the global XANTUS programme. (real world, prospective, observational studies for stroke prevention in patients with atrial fibrillation).
Eur Heart J 2017;
38 (Suppl): 768-769
We do not assume any responsibility for the contents of the web pages of other providers.